Antitrust Europe | 6 Aug 2021
Contents: - Pfizer, Flynn face UK scrutiny over epilepsy drug pricing - Musical-instrument makers receive German antitrust fines - Bayer buys biopharma company Vividion Therapeutics - ThyssenKrupp to sell infrastructure arm...To view the full article, register now.
Already a subscriber? Click here to view full article